The combination treatment also resulted in higher rates of clinical effectiveness than individually provided levosimendan or nesiritide at 1 day ( both P = 0.04 ) or placebo at 1 , 3 or 5 days ( P = 0.002 , 0.006 and 0.009 , respectively ) .